AC
BMRN icon

AXQ Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

AXQ Capital’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,036
Closed -$1.55M – 1014
2025
Q4 		$1.55M Buy
+26,036
New +$1.42M 0.35% 69
2025
Q3 		– Sell
-12,175
Closed -$669K – 597
2025
Q2 		$669K Buy
+12,175
New +$717K 0.22% 145
2024
Q4 		– Sell
-23,022
Closed -$1.62M – 444
2024
Q3 		$1.62M Buy
23,022
+2,323
+11% +$194K 0.49% 37
2024
Q2 		$1.7M Buy
20,699
+5,399
+35% +$449K 0.4% 73
2024
Q1 		$1.34M Buy
15,300
+11,100
+264% +$994K 0.32% 91
2023
Q4 		$405K Sell
4,200
-200
-5% -$17.7K 0.11% 310
2023
Q3 		$389K Sell
4,400
-1,100
-20% -$97.9K 0.14% 258
2023
Q2 		$477K Buy
+5,500
New +$518K 0.59% 41

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return